Review decision – July 2018

Decision to move the existing guidance to the static list

We would like to update you on the decision made regarding the review of the existing guidance on TA348: everolimus for preventing organ rejection in liver transplantation.

No significant new evidence has been identified that would lead to a change in the existing recommendations. As a result, NICE’s Guidance Executive has decided that TA348 should move to the 'static guidance list'. 

Topics on the static list can be considered for review if any new evidence becomes available that is likely to lead to a change in the existing recommendations.

Review decision paper

Stakeholder matrix


This page was last updated: 27 July 2018